DIAGNOSTIC-VALUE OF SERUM PEPSINOGEN-C IN PATIENTS WITH RAISED SERUM CONCENTRATIONS OF PEPSINOGEN-A

被引:12
作者
BIEMOND, I
KREUNING, J
JANSEN, JBM
LAMERS, CBH
机构
[1] Department of Gastroenterology, University Hospital, Building 1, NL-2333 AA Leiden
关键词
D O I
10.1136/gut.34.10.1315
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hypopepsinogenaemia A is often found in patients with gastric atrophy and gastric surgery. In these conditions serum pepsinogen C provides additional diagnostic information, especially when expressed as pepsinogen A:C ratio. Hyperpepsinogenaemia A has been shown in patients with duodenal ulcer disease, Zollinger-Ellison syndrome, hypertrophic gastropathy, chronic renal failure, and during omeprazole treatment. As patients with hyperpepsinogenaemia A often overlap in symptoms, endoscopical findings, and serum gastrin values, this study has evaluated whether measurement of serum pepsinogen C in subjects with hyperpepsinogenaemia A can help in differentiating clinical conditions. Serum concentrations of pepsinogen A and C were measured in serologically Helicobacter pylori negative blood transfusion donors (127) as reference population, and in patients with Zollinger-Ellison syndrome (24), duodenal ulcer (50), hypertrophic gastropathy (5), and chronic renal failure (50), and also in reflux oesophagitis patients on longterm omeprazole treatment (28). A low pepsinogen A:C ratio was found in all patients with hypertrophic gastropathy. A pepsinogen A:C ratio above the critical value of 4.7 was found in 14 (70.0%) of the Zollinger-Ellison patients, two (9.5%) of the duodenal ulcer patients, 11 (25.6%) of the patients with chronic renal failure, and in one (7.1%) of the patients receiving longterm omeprazole treatment. In fact, all but three hyperpepsinogenaemia A patients with a pepsinogen A:C ratio greater than 4-7 and normal renal function had the Zollinger-Ellison syndrome. In patients with hyperpepsinogenaemia A, a low pepsinogen A:C ratio may point to hypertrophic gastropathy, while a pepsinogen A:C ratio greater than 4.7 is suggestive for the Zollinger-Ellison syndrome.
引用
收藏
页码:1315 / 1318
页数:4
相关论文
共 23 条
[1]   EFFECT OF INTERMITTENT ADMINISTRATION OF OMEPRAZOLE ON SERUM PEPSINOGENS IN DUODENAL-ULCER PATIENTS AND HEALTHY-VOLUNTEERS [J].
BIEMOND, I ;
CROBACH, LFSJ ;
JANSEN, JBMJ ;
LAMERS, CBHW .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 29 (04) :465-472
[2]  
BIEMOND I, 1989, J CLIN CHEM CLIN BIO, V27, P19
[3]   EFFECT OF SHORT-TERM OMEPRAZOLE ADMINISTRATION OF SERUM PEPSINOGENS IN RELATION TO FASTING SERUM GASTRIN AND GASTRIC-ACID SECRETION [J].
BIEMOND, I ;
CROBACH, LFSJ ;
JANSEN, JBMJ ;
LAMERS, CBHW .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 37 (04) :345-349
[4]   THE RATIO OF PEPSINOGEN-A TO PEPSINOGEN-C - A SENSITIVE TEST FOR ATROPHIC GASTRITIS [J].
BORCH, K ;
AXELSSON, CK ;
HALGREEN, H ;
NIELSEN, MD ;
LEDIN, T ;
SZESCI, PB .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1989, 24 (07) :870-876
[5]   EFFECT OF PROXIMAL GASTRIC-VAGOTOMY ON SERUM PEPSINOGEN-I AND PEPSINOGEN-II CONCENTRATIONS AND ACID-SECRETION IN DUODENAL-ULCER PATIENTS [J].
FELDMAN, M ;
BLAIR, AJ ;
RICHARDSON, CT ;
SAMLOFF, IM .
DIGESTIVE DISEASES AND SCIENCES, 1988, 33 (07) :824-827
[6]  
FESTEN HPM, 1984, GASTROENTEROLOGY, V87, P1030
[7]   RADIOIMMUNOASSAY OF SERUM GROUP-I AND GROUP-II PEPSINOGENS IN NORMAL CONTROLS AND PATIENTS WITH VARIOUS DISORDERS [J].
ICHINOSE, M ;
MIKI, K ;
FURIHATA, C ;
KAGEYAMA, T ;
HAYASHI, R ;
NIWA, H ;
OKA, H ;
MATSUSHIMA, T ;
TAKAHASHI, K .
CLINICA CHIMICA ACTA, 1982, 126 (02) :183-191
[8]  
LAM SK, 1983, GASTROENTEROLOGY, V84, P834
[9]   SERUM PEPSINOGEN-I IN FAMILIAL MULTIPLE ENDOCRINE NEOPLASIA TYPE-I [J].
LAMERS, CBHW ;
ROTTER, JI ;
JANSEN, JBMJ ;
SAMLOFF, IM .
DIGESTIVE DISEASES AND SCIENCES, 1988, 33 (10) :1274-1276
[10]  
PAIMELA H, 1985, ANN CLIN RES, V17, P105